Anthem Biosciences shares list at 27% premium over IPO price on NSE; should you buy, sell or hold?
Paras Bisht
USER CONSENT
We at moneycontrol use cookies and other tracking technologies to assist you with navigation and determine your location. We a…
Stock lists at 27% premium over IPO price on NSE; should you buy, sell or hold?
